Forecast Of The Day: 3M’s Healthcare Revenue
What?
3M’s (NYSE:MMM) healthcare revenue rose from $7.8 billion in 2020 to $8.5 billion in 2021. Trefis expects the metric to grow to over $9.5 billion by 2023.
Why?
- What’s Next For 3M Stock After A 15% Fall This Year?
- After A 14% Fall This Year Is 3M Stock A Better Pick Over Honeywell?
- What’s Next For 3M Stock After A 24% Fall This Year?
- Should You Pick Starbucks Over 3M Stock For Next Three Years?
- What’s Happening With 3M Stock?
- Will 3M See A Sharp Decline In Q2 Earnings?
We expect growth to be driven by stronger demand for the company’s food safety, medical solutions, oral care solutions, separation, and purification products.
So What?
We think 3M stock is undervalued at current levels. We value MMM at $185 per share, 25% ahead of the current market price.
See Our Complete Analysis For 3M
What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.
| Returns | Mar 2022 MTD [1] |
2022 YTD [1] |
2017-22 Total [2] |
| MMM Return | 0% | -17% | -17% |
| S&P 500 Return | 3% | -5% | 102% |
| Trefis MS Portfolio Return | 2% | -9% | 259% |
[1] Month-to-date and year-to-date as of 3/24/2022
[2] Cumulative total returns since the end of 2016
Invest with Trefis Market Beating Portfolios